Homelessness and Opioid Treatment: What a National Study Reveals About Barriers to Engagement

The Problem

Medication for opioid use disorder (MOUD) saves lives, yet thousands of Americans never complete treatment. A 2023 national study in the Journal of Drug Issues analyzed 188 000 outpatient MOUD episodes and found that individuals experiencing homelessness were significantly less likely to complete or remain in care.

Why It Matters

The findings underscore that homelessness is not just a background variable, it’s an independent predictor of treatment failure. Even when clinics offer MOUD, social determinants of health (SODH), housing instability, poverty, lack of insurance, and recent justice involvement, erode continuity. Understanding this relationship can help clinicians and policymakers design systems that retain rather than lose the most vulnerable.

Key Takeaways

  • Homelessness was present in 8.7 % of treatment episodes and linked to significantly lower completion and retention.
  • Unemployment, no income, and uninsurance co-occurred with homelessness, magnifying risk.
  • Clinical solutions alone are insufficient, structural support (housing, insurance, transportation) must be integrated.
  • Low-threshold and mobile care models can offset barriers.
  • Addressing SODH is a public-health imperative, not a luxury.

Beyond the Mic 

Behind every statistic is a person juggling addiction, trauma, and instability. When our systems fail to retain them, it isn’t a clinical failure, it is a failure of infrastructure and empathy. Integrating housing support into addiction care is not mission creep; it’s evidence-based medicine.

Featured Resources 

→ Listen to the full episode on The Transformed Minds  FULL EPISODE

Stay ready. Stay aware. Stay grounded.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top